The UK has approved a COVID vaccine — here’s what scientists now want to know

The Pfizer–BioNTech vaccine has passed safety and efficacy tests — but researchers still have many questions about how this and other vaccines will perform as they’re rolled out to millions of people. The Pfizer–BioNTech vaccine has passed safety and efficacy tests — but researchers still have many...

Full description

Saved in:

Bibliographic Details
Published in:	Nature (London) 2020-12, Vol.588 (7837), p.205-206
Main Authors:	Ledford, Heidi, Cyranoski, David, Van Noorden, Richard
Format:	Article
Language:	English
Subjects:	631/250/590 631/326/596/4130 Adolescent Age Factors Aged Aged, 80 and over Aging - immunology Beliefs, opinions and attitudes Biomedical Research - trends Child, Preschool Clinical Trials as Topic COVID-19 - immunology COVID-19 - prevention & control COVID-19 - transmission COVID-19 - virology COVID-19 Vaccines - adverse effects COVID-19 Vaccines - immunology COVID-19 Vaccines - supply & distribution Demographic aspects Drug Approval Drug Industry Drug Monitoring Female Forecasts and trends Health aspects Humanities and Social Sciences Humans Immune Evasion Immunity Microbial mutation multidisciplinary News Explainer Observations Pharmacovigilance Pregnancy Safety and security measures SARS-CoV-2 - genetics SARS-CoV-2 - immunology Science Scientists Self Report Time Factors Uncertainty United Kingdom Vaccination Virus Shedding
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!